We are live on ! Find out more
KALA icon

KALA BIO

55 hedge funds and large institutions have $249M invested in KALA BIO in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

6% more funds holding

Funds holding: 52 → 55 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6.35% less ownership

Funds ownership: 66.36% → 60.01% (-6.4%)

11% less capital inflows, than outflows

Capital inflows: $15.2M | Capital outflows: $17M

13% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 8

28% less call options, than puts

Call options by funds: $2.97M | Put options by funds: $4.12M

Holders
55
Holders Change
+3
Holders Change %
+5.77%
% of All Funds
0.96%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
7
Reduced
8
Closed
8
Calls
$2.97​M
Puts
$4.12​M
Net Calls
-⁠$1.15​M
Net Calls Change
-⁠$739​K

KALA Hedge Fund Activity: Q1 2021 in Review

55 of the 5,709 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q1 2021, worth a combined $249M — down 1.4% from $252M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new KALA positions and 8 closed out — a net gain of 3 holders — while 7 added to existing stakes and 8 trimmed.

The largest buyer was Caxton Corporation, adding an estimated $2.34M. The largest seller was Bank of America, cutting an estimated $3.51M.

  • 55 institutional investors held KALA BIO (KALA) as of Q1 2021, up from 52 in Q4 2020.
  • Funds reported $249M of KALA BIO stock for Q1 2021, down 1.4% quarter-over-quarter.
  • 11 funds opened new KALA BIO positions in Q1 2021 and 8 closed out, a net change of +3 holders.
  • The largest KALA BIO buyer in Q1 2021 was Caxton Corporation, an estimated $2.34M added.
  • The largest KALA BIO seller in Q1 2021 was Bank of America, an estimated $3.51M sold.

Based on aggregated 13F filings for Q1 2021.